SCHEMBL6287286

SCHEMBL6287286

CC(=O)CCC(=O)CCc1ccccc1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 6/20 0.53
PTGER3 P43115 6/20 0.53
PTGER1 P34995 5/20 0.53
PTGER2 P43116 5/20 0.53
KMT2A Q03164 1/20 0.47
FOLH1 Q04609 1/20 0.45
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.43
FFAR1 O14842 4/20 0.43
FFAR4 Q5NUL3 4/20 0.43
IAPP P10997 2/20 0.42
DPP4 P27487 1/20 0.42
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
CNR2 P34972 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12225988 0.90 PTGER4 (0.58) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL27442369 0.90 PTGER4 (0.62) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL11038460 0.81 PTGER1 (0.49) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL1261128 0.79 PTGER4 (0.77) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL31212507 0.79 PTGER4 (0.77) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL29277857 0.79 IAPP (0.51) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL6053663 0.78 PTGER4 (0.81) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL1567197 0.78 PTGER4 (0.60) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL6206188 0.76 PTGER4 (0.58) PTGER4PTGER3PTGER1PTGER2KMT2A
SCHEMBL8962348 0.75 ALDH1A1 (0.77) KMT2AALDH1A1FFAR1CNR2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6911468-B2 Tyrosine phosphatase inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-06-28 US disclosed
US-20030144338-A1 Tyrosine phosphatase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-07-31 US disclosed
EP-1284260-A1 TYROSINE PHOSPHATASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144338-A1 Tyrosine phosphatase inhibitors PTPRC, PTPN1, PTPRM PTGER4 4389/4885PTGER3 4460/4885PTGER1 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.